The Difference in Mortality, Seroconversion, and Duration of Hospitalization Between Patients With and Without Anti-CD20 Antibody Therapy Among Hematological Malignancies With Superadded COVID-19 Infection

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA(2023)

引用 0|浏览4
暂无评分
关键词
aggressive B-cell lymphoma, COVID-19, anti-CD20, hematologic malignancy, mortality, lymphoma
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要